[1]
|
Bargman, J.M. and Skorecki, K. (2011) Chronic kidney disease. In: Longo, D., Fauci, A., Kasper, D., Hauser, S., Jameson, J. and Loscalzo, J., Eds., Harrison’s Principles of Internal Medicine, 18th Edition, McGraw Hill, New York, 2308-2321.
|
[2]
|
McMahon, L.P. and Parfrey, P.S. (2008) Cardiovascular aspects of chronic kidney disease. In: Brenner, B.M. and Rector, F.C., Eds., The Kidney, 8th Edition, Saunders, Philadelphia, 1697-1727.
|
[3]
|
Ritz, E., Adamczack, M. and Wiecek, A. Metabolic and Endocrine Dysfunctions in Uremia. In: Schrier, R.W., Ed., Diseases of the Kidney and Urinary Tract, 8th Edition, Lippincott Williams & Wilkins, Philadelphia, 96, 2502-2538.
|
[4]
|
Fadda, G.Z. and Massry, S.G. (1995) Glucose and insulin metabolism. Metabolism and endocrine disturbances in uremia. In: Massry, S.G. and Glassock, R.J., Eds., Massry and Glassok’s Textbook of Clinical Nephrology, Lippincott Williams & Wilkins, Philadelphia, 1390-1394.
|
[5]
|
Matthews, D.R., Hosker, J.B., Rudenski, A.S., Naylor, B.A., Treacher, D.F. and Turner, R.C. (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
doi:10.1007/BF00280883
|
[6]
|
Chen, J., Muntner, P., Hamm, L.L., Fonseca, V., Batuman, V., Whelton, P.K. and He, J. (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. Journal of the American Society of Nephrology, 14, 469-477. doi:10.1097/01.ASN.0000046029.53933.09
|
[7]
|
Kobayashi, S., Maesato, K., Moriya, H., Ohtake, T. and Ikeda, T. (2005) Insulin resistance in patients with chronic kidney disease. American Journal of Kidney Disease, 45, 275-280. doi:10.1053/j.ajkd.2004.09.034
|
[8]
|
Cases, A. and Coll, E. (2005) Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney International, 68, 87-93.
doi:10.1111/j.1523-1755.2005.09916.x
|
[9]
|
Menon, V. (2005) The epidemiology of chronic kidney disease, stages 1 to 4 and cardiovascular disease: A high risk combination. American Journal of Kidney Diease, 45, 223-232. doi:10.1053/j.ajkd.2004.09.022
|
[10]
|
Madero, M., Sarnak, M.J., Wang, X.L., Greene, T., Beck, G.J., Kusek, J.W., Collins, A.J., Levey, A.S. and Menon, V. (2009) Uric acid and long-term outcomes in CKD. American Journal of Kidney Disease, 2009; 53, 796-803.
doi:10.1053/j.ajkd.2008.12.021
|
[11]
|
Szeto, C.-C., Chow, K.-M., Woo, K.-S., Chook, P., Kwan, B.C.H., Leung, C.-B. and Li, P.K.T. (2007) Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. Journal of the American Society of Nephrology, 18, 1966-1972
|
[12]
|
Fox, E.R., Benjamin, E.J., Sarpong, D.F., Nagarajarao, H., Taylor, J.K., Steffes, M.W. and Salahudeen, A.K. (2010) The relation of C-reactive protein to chronic kidney disease in African Americans: The Jackson heart study. BMC Nephrology, 11.
|
[13]
|
Das, S., Dash, G.K., Behera, M., Routray, S.N., Minz, N.T. and Pattnaik, M. (2007) Prevalence of metabolic syndrome in angiographically established coronary artery disease patients. South Asian Journal of Preventive Cardiology, 11, 93-100.
|